Fundraising FoxDebiopharm Innovation Fund
Corporate VCLausanne · Pre-Seed–Late Stage · 18 people tracked
Find your way into Debiopharm Innovation Fund
Each arrow is one introduction. Sign up to fill in the first one.
Ask David Mathewson to introduce you to Kavita Patel
You →David · together at SEAF →Kavita
Ask Jamie Chen to introduce you to Marc Cikes
You →Jamie · together at BC Platforms →Marc
Ask Sam Okafor to introduce you to Vincent Lepreux
You →Sam · together at WhiteLab Genomics →Vincent
- David Shin174 people can intro you
- Chris Thomas106 people can intro you
- Bertrand Ducrey56 people can intro you
Sign up to find every way you can get introduced to Debiopharm Innovation Fund
- Your email: who you already know at Debiopharm Innovation Fund, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Debiopharm Innovation Fund team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
As Debiopharm's corporate venture arm, the fund backs digital health and health tech startups working to transform pharmaceutical R&D and cancer care. Beyond capital, it offers portfolio companies strategic guidance, deepened market knowledge, pharma expertise, and access to Debiopharm's network, positioning itself as a launchpad for scalable, investment-ready companies aiming to improve outcomes for patients globally.
Source: firm website, verified Aug 3, 2026.
Team · 18 people
from the firm's website & curated & public directories
What they invest in
from 20 of 21 portfolio companiesAI & Machine Learning ×17Biotech ×13Medical Devices ×13Healthtech ×12Digital Health ×8SaaS ×5Data & Infrastructure ×4Deep Tech ×3
HQs:United States×5France×3Germany×2United Kingdom×2Belgium×1Canada×1
Who they back
founder profiles across 8 portfolio companiesFounding team size:solo founder×22 founders×33 founders×24+ founders×1
What their founders studiedfrom 11 founders with field-of-study data
Engineering ×4Business & Management ×2Life Sciences ×2Mathematics & Statistics ×2
Where their founders worked beforefrom 12 founders with career history
Baylor College of Medicine ×2IBM ×2Owkin ×2
Investments · 21 tracked
founders shown can be your intro pathBy year:2023 · 42022 · 12016 · 16 dated
MedaSystems builds a software platform that automates workflows, collects real-world data, and connects physicians with pharmaceutical manufacturers to manage drugs under pre-approval and expanded-access pathways.
Digital HealthHealthtechMedical DevicesSaaSSilicon Valley, US
Brian Irwin(Chief Executive Officer)inJeffrey Thibeault(Chief Technology Officer)in
Co-investorsNina Capital
Octozi provides AI-powered automation for clinical data workflows including cleaning, review, reconciliation, reporting, and operations in clinical trials.
AI & Machine LearningEnterprise SoftwareMedical Devices
Amit Patel(Founder)inMatt Purri, PhD(Founder)in
Co-investorsEntrepreneurs Roundtable Accelerator (ERA)Remarkable VenturesSurface Ventures
StratifAI develops AI-driven multimodal biomarkers for precision oncology, using its platform to link routine H&E histology and RNASeq gene expression data to patient outcomes for prognostic and predictive insights.
AI & Machine LearningBiotechHealthtechMedical DevicesBerlin, DE
Daniel Truhn(Co-Founder & Chief Medical Officer)inFiras Khader(Co-Founder & CTO)inJakob Nikolas Kather(Co-Founder & CSO)Omar El Nahhas(CEO & Co-founder)in
Co-investorsNeulogy VenturesPICUS CAPITALAlvenHeliad AGHV Capital
Altis provides independent, IC-grade investment diligence and market research on private companies from Seed to Series D+, working outside-in without access to management or data rooms.
AI & Machine LearningData & InfrastructureFintech
Co-investorsPrimary Venture PartnersBenchstrength PartnersGalapagos Capital
Altis Labs provides a web-based platform that applies AI models to medical imaging data to generate reproducible predictions and quantifications for clinical trials.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesToronto, CA
Felix Baldauf-Lenschen(Founder & CEO)inJohn(CTO)
Co-investorsCreative Destruction Lab (CDL)FusionOrbiMedBenchstrength Partners
BC Platforms provides AI-enabled, federated data technology and predictive analytics that give healthcare and life sciences organizations access to real-world patient and genomic data for drug development and precision medicine.
AI & Machine LearningBiotechData & InfrastructureHealthtechZurich, CH
Nino da Silva(Executive Officer)inTero Silvola(Executive Officer, Director)inMukhtar Ahmed(Chief Executive Officer)in
BoardHannu Vaajoensuu(Director)Jari Heikkinen(Director)Erich Platzer(Director)
Co-investorsJolt CapitalStartAngels Network
Genialis is a precision oncology company that applies data analysis to help drug developers understand mechanisms of action, resistance, and patient stratification for cancer therapies.
AI & Machine LearningBiotechDigital HealthMedical DevicesBoston, US
Miha Štajdohar(Executive Officer, Director)inRafael Rosengarten(Chief Executive Officer and Co-founder)inLuka Ausec(Executive Officer)inHamzeh Abdul-Hadi(Director)Tjasa Krisper Kutin(Executive Officer)
Co-investorsAngelini VenturesTaiwania CapitalFirst Star VenturesScaleX Venturesredalpine
Spaya is an AI-powered retrosynthesis platform that identifies synthetic routes to target compounds by converting them into commercially available starting materials.
AI & Machine LearningBiotechDeep TechMedical DevicesParis, FR
Yann(Co-founder and CEO)Quentin(Co-founder and CSO)Nicolas(Co-founder and CTO)
Co-investorsM VenturesOmnes Capital
Medable provides a cloud-based platform for clinical research that uses AI and digital tools to accelerate the development of therapies by improving the quality, reach, and efficiency of clinical trials.
AI & Machine LearningBiotechCloud ComputingDigital HealthHealthtechMedical DevicesSaaSPalo Alto, US
Michelle Longmire(Founder)Timothy R. Smith(Executive Officer, Director)Perry Robinson(Executive Officer)inRolland-Yves Mauvernay
BoardYoung A. Sohn(Director)Richard Lim(Director)in
Co-investorsACVC PartnersConnectivity VenturesHealthX VenturesInformed Ventures Advisors, LlcKin VenturesObvious Ventures+8 more
ModernVivo is a software platform that automates literature review and analysis for in vivo study design in pharmaceutical research and preclinical development.
AI & Machine LearningBiotechMedical Devices
Ian Levine(Founder)in
Vedaly provides AI, data analytics, and decision support tools for biopharma companies to integrate insights into scientific and strategic planning.
AI & Machine LearningBiotechData & InfrastructureHealthtechSaaSMartinsried, DE
Tanya Aneichyk(PhD, CEO)in
Co-investorsTechstars
Concr combines AI-driven computational methods with biological expertise to develop precision oncology tools that improve drug selection and delivery for cancer patients.
AI & Machine LearningBiotechMedical DevicesGlasgow, GB
Matthew Griffiths(Chief Technology Officer & Co-Founder)Uzma Asghar(Advisor, Medical Strategy & Co-Founder)Matt Foster(Non-Executive Director (Australia) & Co-Founder)
Co-investorsAvonmore DevelopmentsCambridge Angels groupDeep Science VenturesOncology Ventures
Raidium builds an AI-native PACS viewer embedding a vision-language foundation model to support radiologists across research and clinical work, including automated tumor measurement and lesion segmentation.
AI & Machine LearningDigital HealthMedical DevicesParis, FR
Paul Herent, M.D., Msc(Founder)inPaul Hérent(Co-Founder and CEO)inPierre Manceron(Co-Founder and CSO)inSebastian Schwarz(COO)inDamien Benard(CFO)in
Co-investorsFounders FutureGalion.exeKurma PartnersNewfund CapitalStartX
Stitch is a platform for clinical research sites that provides participants with a digital interface for their study visits, appointment reminders, and feedback, while reducing administrative workload for study coordinators.
Digital HealthHealthtechSaaSLondon, GB
Mike Sterling(Founder)in
Co-investorsBoost Capital PartnersForm VenturesOncology VenturesBenchmarkY Combinator
Strategikon Pharma develops Clinical Maestro, a software platform for managing clinical business operations including budgeting, sourcing, contracting, and vendor management, with AI-driven cost benchmarking tools.
AI & Machine LearningBiotechHealthtechSaaSSan Francisco, US
Anca Copaescu(Founder)inMark Di Ianni(Executive Officer, Director, Promoter)Paulo Carvalho(Executive Officer)inMark Weinstein(Executive Officer, Director)in
BoardRob Hess(Director)Vincent Lepreux(Director)in
Co-investorsAlumni VenturesBand of AngelsHearstLabBascom VenturesDecathlon Capital PartnersGolden Seeds+3 more
Tune Insight develops privacy-preserving data collaboration software that combines homomorphic encryption, secure multiparty computation, differential privacy, and federated learning, allowing organizations to derive insights without directly sharing or manipulating raw data.
CybersecurityData & InfrastructureDeep TechDigital HealthHealthtechBelgium, BE
Co-investors14Peaks CapitalInflection.xyzFounderful
VeriSIM uses machine learning and computational simulation to accelerate drug development, replacing traditional trial-and-error experimentation with computational prediction to improve success rates and reduce animal testing.
AI & Machine LearningBiotechDigital HealthMedical DevicesSan Francisco, US
Jo Varshney(Founder & Chief Executive Officer)inDr. Vivek Gupta, Ph.D.(Scientific Co-Founder)
Co-investorsAmplify PartnersCerity Partners VenturesColorcon VenturesIntel CapitalLoup VenturesOCA Ventures+6 more
ViewsML applies AI to support the development and delivery of precision medicines, including virtual IHC technology for pathology.
AI & Machine LearningBiotechHealthtechMedical Devices
Kenneth To(Chief Executive Officer)inKeith Jalbert(Chief Commercial Officer)Christopher Jackson(Chief Scientific Officer)inGeorge Hennen(Chief Technology Officer)inRafay Azhar(Medical Director)in
Co-investorsSFU VentureLabsSwan Venture FundWittington VenturesWUTIF CapitalMayo Clinic Ventures
WhiteLab Genomics uses AI and computational methods to analyze biological data and accelerate genomic drug discovery and development.
AI & Machine LearningBiotechDeep TechHealthtechParis, FR
David Delbourgo(Founder)inJulien Cottineau(Founder)in
Co-investorsY CombinatorAtlantic Vantage PointOmnes Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
HopeAI
Portfolio news
latest coverage across their companiesOctozi · thesaasnews.com · Jul 8, 2026
Medable · trysignalbase.com · Mar 25, 2026
Frequently asked questions
- How many investments has Debiopharm Innovation Fund made?
- Debiopharm Innovation Fund has 21 tracked investments.
- What stage does Debiopharm Innovation Fund invest at?
- Debiopharm Innovation Fund invests at the Pre-Seed, Seed, Series A, Series B, Late Stage stages.
- What is Debiopharm Innovation Fund's typical check size?
- Debiopharm Innovation Fund typically writes checks of $1M – $5M.
- What sectors does Debiopharm Innovation Fund focus on?
- Debiopharm Innovation Fund focuses on Biotech, Digital Health, Healthtech.
- Where is Debiopharm Innovation Fund located?
- Debiopharm Innovation Fund is headquartered in Lausanne, CH.
- Does Debiopharm Innovation Fund lead rounds?
- Yes, Debiopharm Innovation Fund leads investment rounds.
- Who does Debiopharm Innovation Fund co-invest with?
- Debiopharm Innovation Fund most often shares deals with Oncology Ventures, Newfund Capital, PROOF, among 40 tracked co-investors.
Media · Podcasts & interviews
featuring the teamFH23 - An interview with Marc Cikes, Managing Director Debiopharm, and Tom Gibbs, Investment Director Debiopharm Innovation Fund
Marc Cikes · vimeo.com
Debiopharm at AACR: First Clinical Data from the MYTHIC Trial (zedoresertib + lunresertib)
DebiopharmTV
Overcoming ADC Linker Challenges: The MultiLINK™ Technology Suite
DebiopharmTV
ADC Talks - Olivier Cochet
DebiopharmTV
ADC Talks - Sophie and Marianna
DebiopharmTV
Antoine’s Journey Finding Purpose at Debiopharm
DebiopharmTV
Images
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
.png)
General Catalyst is a venture capital firm operating as a partnership focused on company building and accelerating the growth of the businesses it backs.